James Wentworth
Corporate Officer/Principal at TRANSGENE
Profile
James Wentworth is currently the Chief Business Officer & Vice President at Transgene SA. Previously, he worked as the Director of Business Development & Strategy at Adaptimmune Ltd.
He completed his undergraduate and doctorate degrees at the University of Bristol and holds an MBA from the International Institute for Management Development.
James Wentworth active positions
| Companies | Position | Start |
|---|---|---|
| TRANSGENE | Corporate Officer/Principal | 21/01/2024 |
Former positions of James Wentworth
| Companies | Position | End |
|---|---|---|
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Training of James Wentworth
| University of Bristol | Doctorate Degree |
| International Institute for Management Development | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TRANSGENE | Health Technology |
| Private companies | 1 |
|---|---|
Adaptimmune Ltd.
Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom. | Health Services |
- Stock Market
- Insiders
- James Wentworth
